U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Neuroblastoma cell lines treated with DAC (2'-deoxy-5-azacytidine), a DNA-methylation inhibitor

(Submitter supplied) 8 neuroblastoma (NB) cell lines (CLB-GA, IMR-32, SH-SY5Y, N206, CHP-902R, LAN-2, SK-N-AS, SJNB-1) were profiled on the Affymetrix HGU-133plus2,0 platform before and after treatment with DAC (2'-deoxy-5-azacytidine) to investigate the influence on expression after inhibiting DNA-methylation
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
16 Samples
Download data: CEL
Series
Accession:
GSE31229
ID:
200031229
2.

A genome wide methylation map of neuroblastoma cell lines

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing; Expression profiling by array
Platforms:
GPL10999 GPL570
24 Samples
Download data: BED, CEL, WIG
Series
Accession:
GSE31355
ID:
200031355
3.

Methylation map of 8 neuroblastoma cell lines: NGS after MBD2-capture

(Submitter supplied) 8 neuroblastoma (NB) cell lines (CLB-GA, IMR-32, SH-SY5Y, N206, CHP-902R, LAN-2, SK-N-AS, SJNB-1) their methylome is determined by sequencing after MBD2-capture using MethylCollector (ActiveMotif)
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL10999
8 Samples
Download data: BED, WIG
Series
Accession:
GSE31353
ID:
200031353
4.

Methyl-CpG-binding domain (MBD) sequencing of neuroblastoma tumors

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platforms:
GPL10999 GPL11154
162 Samples
Download data: BED, TDF, WIG
Series
Accession:
GSE69279
ID:
200069279
5.

Methyl-CpG-binding domain (MBD) sequencing of 15 primary stage 4S neuroblastoma tumors

(Submitter supplied) The DNA methylome of 15 primary stage 4S neuroblastoma tumors is profiled by enrichment with a methyl-CpG-binding domain (MBD) and massively parallel sequencing
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL11154
30 Samples
Download data: BED, TDF, WIG
Series
Accession:
GSE69268
ID:
200069268
6.

Methyl-CpG-binding domain (MBD) sequencing of 45 primary neuroblastoma tumors

(Submitter supplied) The DNA methylome of 45 primary neuroblastoma tumors is profiled by enrichment with a methyl-CpG-binding domain (MBD) and massively parallel sequencing
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL11154
90 Samples
Download data: BED, TDF, WIG
Series
Accession:
GSE69243
ID:
200069243
7.

Methyl-CpG-binding domain (MBD) sequencing of 42 primary neuroblastoma tumors

(Submitter supplied) The DNA methylome of 42 primary neuroblastoma tumors is profiled by enrichment with a methyl-CpG-binding domain (MBD) and massively parallel sequencing
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL10999
42 Samples
Download data: BED, TDF, WIG
Series
Accession:
GSE69224
ID:
200069224
8.

Analysis of genome-wide methylation and gene expression induced by decitabine treatment in HL60 leukemia cell line

(Submitter supplied) Epigenetic changes play a role in the pathogenesis of myeloid malignancies and hypomethylating agents have shown efficacy in these diseases. We studied the apoptotic effect, the genome-wide methylation and gene expression profiles in HL60 cells following decitabine treatment, using micro-array technologies. Decitabine treatment resulted in a decrease in global DNA methylation, corresponding to 4876 probeset IDs with significantly reduced methylation levels, while expression of 2583 IDs was induced. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Methylation profiling by genome tiling array
Platforms:
GPL570 GPL5082
12 Samples
Download data: CEL, TXT
Series
Accession:
GSE24224
ID:
200024224
9.

Genome-wide methylation and expression profiling study identifies candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer.

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Methylation profiling by array
Platforms:
GPL8490 GPL570
46 Samples
Download data: CEL
Series
Accession:
GSE28648
ID:
200028648
10.

Genome-wide Methylation Profiling Identifies Candidate DNA Methylation Drivers of Acquired Cisplatin Resistance in Ovarian Cancer.

(Submitter supplied) Multiple DNA methylation changes have been associated with the acquisition of drug resistance; however it remains uncertain how many of these changes may represent critical DNA methylation drivers of chemoresistance. Using genome-wide DNA methylation profiling across 27,578 CpG sites on Illumina HumanMethylation27 bead array we identified loci at 4092 genes becoming hypermethylated in the chemoresistant A2780/cp70 ovarian tumour cell line compared to the parental sensitive A2780 line. more...
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL8490
31 Samples
Download data: TXT
Series
Accession:
GSE28647
ID:
200028647
11.

Gene expression profiling in A2780, CP70 and CP70 following Decitabine and/or PXD101 treatment

(Submitter supplied) Multiple DNA methylation changes have been associated with the acquisition of drug resistance; however it remains uncertain how many of these changes may represent critical DNA methylation drivers of chemoresistance. Using gene expression profiling method on HGU133plus2 array, we identified a total of 1370 genes showing significant gene expression changes with 687 genes going up and 683 genes going down in the resistant (cp70) versus sensitive cell lines (A2780) by Rank Product (FDR<5%). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
15 Samples
Download data: CEL
Series
Accession:
GSE28646
ID:
200028646
12.

Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma

(Submitter supplied) Single-color gene expression profiles from IMR-32 neuroblastoma cell lines were generated using 44K oligonucleotide microarrays. To gain insights into the molecular processes occurring upon TFAP2B re-expression, we performed gene expression measurements in TFAP2B and GFP expressing transgenic IMR-32 neuroblastoma cell lines at d2 and d7 of transgene induction.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL16876
4 Samples
Download data: TXT
Series
Accession:
GSE74350
ID:
200074350
13.

Genome-wide methylation profiling of ovarian cancer patient-derived xenograft (PDXs) treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

(Submitter supplied) Background: In high-grade serous ovarian cancer (HGSOC) intrinsic and/or acquired resistance against platinum-containing chemotherapy is a major obstacle for successful treatment. A low frequency of somatic mutations, but frequent epigenetic alterations including DNA methylation in HGSOC tumors, presents the cancer epigenome as a relevant target for innovative therapy. Patient-derived xenografts (PDXs) supposedly are good preclinical models for identifying novel drug targets. more...
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platform:
GPL13534
22 Samples
Download data: IDAT
Series
Accession:
GSE81438
ID:
200081438
14.

5-aza-2-deoxycytidine treatment of Swarm rat chondrosarcoma cells

(Submitter supplied) The puropose of this experiment was to identify gene expression changes that result from 5-aza-2-deoxycytidine induced DNA demethylation of Swarm rat chondrosarcoma cells. The gene expression profiles of untreated Swarm rat chondrosarcoma cells were compared to the gene expression profiles of Swarm rat chondrosarcoma cells that were treated for 5 passages with a low dose of 5-aza-2-deoxycytidine (0.1uM).
Organism:
Rattus norvegicus
Type:
Expression profiling by array
Platform:
GPL8990
5 Samples
Download data: PAIR
Series
Accession:
GSE17598
ID:
200017598
15.

Random forest-based modelling to detect novel biomarkers for prostate cancer progression

(Submitter supplied) The clinical course of prostate cancer (PCa) is highly variable, demanding an individualized approach to therapy and robust prognostic markers for treatment decisions. We here present a random forest-based classification model to predict aggressive behaviour of PCa. DNA methylation changes between PCa cases with good or poor prognosis (discovery cohort with n=78) were used as input. The model was validated with data from two independent PCa cohorts from ICGC and TCGA. more...
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platform:
GPL18809
70 Samples
Download data: IDAT, TXT
Series
Accession:
GSE127985
ID:
200127985
16.

Genome-wide screen for promoter methylation in NSCLC identifies novel methylation markers for multiple malignancies

(Submitter supplied) BACKGROUND: Promoter hypermethylation coupled with loss of heterozygosity at the same locus results in loss of gene function in many tumor cells. The "rules" governing which genes are methylated during the pathogenesis of individual cancers, how specific methylation profiles are initially established, or what determines tumor type-specific methylation are unknown. However, DNA methylation markers that are highly specific and sensitive for common tumors would be useful for the early detection of cancer, and those required for the malignant phenotype would identify pathways important as therapeutic targets. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
7 Samples
Download data: CEL
Series
Accession:
GSE6695
ID:
200006695
17.

A Genome-wide Screen for Hypermethylated Genes in Lung Cancer

(Submitter supplied) Abstract Background: Promoter hypermethylation coupled with loss of heterozygosity at the same locus results in loss of gene function in many tumor cells. The “rules” governing which genes are methylated during the pathogenesis of individual cancers, how specific methylation profiles are initially established, or what determines tumor-type specific methylation are unknown. However, DNA methylation markers that are highly specific and sensitive for common tumors would be useful for the early detection of cancer, and those required for the malignant phenotype identify pathways important as therapeutic targets. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
42 Samples
Download data: CEL
Series
Accession:
GSE5816
ID:
200005816
18.

DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma.

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array; Expression profiling by array
Platforms:
GPL13667 GPL13534
64 Samples
Download data: CEL
Series
Accession:
GSE54721
ID:
200054721
19.

DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma [gene expression]

(Submitter supplied) DNA methylation changes in neuroblastoma, a clinically-heterogeneous pediatric tumor, have been described essentially in promoter regions. We analyzed the DNA methylome of neuroblastoma using high-density microarrays and observed differential methylation not only in promoters but also in intragenic and intergenic regions at both CpG and non-CpG sites. These epigenetic changes showed a non-random distribution relative functional chromatin domains, and targeted development and cancer-related genes, relevant for neuroblastoma pathogenesis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13667
23 Samples
Download data: CEL
Series
Accession:
GSE54720
ID:
200054720
20.

DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma [methylation]

(Submitter supplied) DNA methylation changes in neuroblastoma, a clinically-heterogeneous pediatric tumor, have been described essentially in promoter regions. We analyzed the DNA methylome of neuroblastoma using high-density microarrays and observed differential methylation not only in promoters but also in intragenic and intergenic regions at both CpG and non-CpG sites. These epigenetic changes showed a non-random distribution relative functional chromatin domains, and targeted development and cancer-related genes, relevant for neuroblastoma pathogenesis. more...
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platform:
GPL13534
41 Samples
Download data: TXT
Series
Accession:
GSE54719
ID:
200054719
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_674d3102f363504c2f3d4c7e|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center